One-week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1% cream: a placebo-controlled study
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 3 (4) , 181-184
- https://doi.org/10.3109/09546639209088719
Abstract
In a multicentre double-blind randomized parallel-group study, 31 patients who had mycologically proven tinea corporis or tinea cruris were treated topically with either terbinafine 1% cream or its vehicle, applied once daily for 1 week. The percentage of patients 'effectively treated' (combined mycological and clinical outcome) was 86% for terbinafine compared with 35% for placebo (P = 0.01, Fisher's Exact test, two tailed). No adverse events were reported during the study. Topical terbinafine 1% cream used once daily for 1 week is an effective and well-tolerated treatment for tinea corporis and tinea cruris.Keywords
This publication has 7 references indexed in Scilit:
- Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream: A placebo controlled studyJournal of Dermatological Treatment, 1991
- Treatment of tinea cruris with topical terbinafineJournal of the American Academy of Dermatology, 1990
- Efficacy and tolerability of topical terbinafine in the treatment of tinea crurisJournal of the American Academy of Dermatology, 1990
- Clinical efficacy and tolerability of terbinafine (Lamisil)-a new topical and systemic fungicidal drug for treatment of dermatomycosesClinical and Experimental Dermatology, 1989
- In vitro activity of terbinafineClinical and Experimental Dermatology, 1989
- Antifungal activity of the allylamine derivative terbinafine in vitroAntimicrobial Agents and Chemotherapy, 1987
- Mechanisms of Action of the Antimycotic ImidazolesJournal of Investigative Dermatology, 1981